• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS NUSSLOCH GMBH HISTOCORE PEGASUS; PROCESSOR, TISSUE, AUTOMATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS NUSSLOCH GMBH HISTOCORE PEGASUS; PROCESSOR, TISSUE, AUTOMATED Back to Search Results
Model Number HISTOCORE PEGASUS
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Date 02/02/2024
Event Type  malfunction  
Event Description
On (b)(6) 2024 leica biosystems received a complaint that the customer experienced suboptimal tissue processing on their histocore pegasus.As a result, 3 tissue samples need to be recollected (2 gastric biopsy samples and 1 esophageal sample).
 
Manufacturer Narrative
An investigation of the incident is currently underway and a follow up will be submitted should additional information become available following the investigation.
 
Manufacturer Narrative
As part of our post market surveillance, we have identified an issue related to poorly processed or damaged biopsy tissue specimens on the histocore pegasus and histocore pegasus plus systems.The problem is associated with reagent levels exceeding the maximum fill level marks on reagent bottles or in the paraffin tanks.The overfilling of reagents by users, excess reagent carried from the basket during initial loading, or excessive reagent in the biopsy pads/wraps can lead to reagent levels surpassing the maximum fill level mark.As a result, excess reagent may flow into other bottles through the air manifold during a processing protocol, causing crosscontamination.Due to the fact, that we have received one (1) more mdr regarding the safety issue described, it has been decided to initiate a field action.A capa has been started to identify detailed countermeasures.The first step to address this issue will be to send a fa-notice to the customer to provide information about the possibly hazardous situations regarding reagent overfilling.In addition, the fa-notice will contain information that leica biosystems service will contact the customer to perform an upgrade of the instrument.The second step will be that leica biosystems service will contact the customer to schedule the upgrade of the instrument with the new manifold.Three (3) attempts will be made to contact each customer.The general strategy is to use at least 2 different channels like email and phone contact.There may be some country specific exemptions.Effectiveness check/target response rate: for the countries where this fa is reportable, we aim for a 100 % response rate.For countries where the fa is not reportable, we aim for a 75% response rate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HISTOCORE PEGASUS
Type of Device
PROCESSOR, TISSUE, AUTOMATED
Manufacturer (Section D)
LEICA BIOSYSTEMS NUSSLOCH GMBH
heidelbergerstrasse 17-19
nussloch 69226
GM  69226
Manufacturer (Section G)
LEICA MICROSYSTEMS LTD. SHANGHAI
building 1, 258 jinzang road
20120 6
CH   201206
Manufacturer Contact
robert gropp
heidelbergerstr. 17-19
nussloch 69226
GM   69226
6224143345
MDR Report Key18814625
MDR Text Key336615263
Report Number8010478-2024-00003
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHISTOCORE PEGASUS
Device Catalogue Number14048858005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Distributor Facility Aware Date02/02/2024
Initial Date Manufacturer Received 02/02/2024
Initial Date FDA Received03/01/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-